Examination of Nociscan Impact on Discogenic Low Back Pain Surgical Outcomes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Examination of Nociscan Impact on Discogenic Low Back Pain Surgical Outcomes — Stella

Recruiting

Back to Discogenic Low Back Pain trials

Trial locations(8 sites)

United States

Todd H. Lanman, M.D Inc, Beverly Hills, California

Scripps Health, La Jolla, California

USC Keck Medical Center, Los Angeles, California

University of Miami, Miami, Florida

Northwestern University, Chicago, Illinois

Key details

Sponsor

Aclarion

Collaborators

MCRA

Enrollment target

~300 participants

Started

June 2025

Primary completion

September 2027

Age range

18 Years – 70 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov